![](images/null.gif) |
![](images/null.gif) |
![](images/null.gif) |
|
48 Wk Efficacy and Safety of Switching Virologically Stable HIV-1 Patients from Nevirapine IR 200 mg BID to Nevirapine XR 400 mg QD (TRANxITION)
|
|
|
Reported by Jules Levin
Glasgow Nov 7-11 2010-11-18
K. Arasteh*, D. Ward, A. Plettenberg, JM, Livrozet, A Winston, C Cordes, E. Wang, A-M. Quinson
* EPIMED c/o Vivantes Auguste-Viktoria-Klinikum, Berlin, Germany
![](../images/112110/112110-22/tran-1.gif)
![](../images/112110/112110-22/obj-2.gif)
![](../images/112110/112110-22/full-3.gif)
![](../images/112110/112110-22/vs-4.gif)
|
|
|
![](images/null.gif) |
![](images/null.gif) |
|
|